ECRM_1170x120_4-15-17

AmerisourceBergen Drug Corp.

WBA increases stake in AmerisourceBergen

WBA increases stake in AmerisourceBergen

DEERFIELD, Ill. — Walgreens Boots Alliance Inc. said on Friday that it had agreed with AmerisourceBergen Corp. to amend the second tranche of warrants held by WBA to purchase AmerisourceBergen common stock to allow immediate exercise of the warrants, giving WBA nearly 24% of AmerisourceBergen’s outstanding equity. The warrants were originally scheduled to be exercisable

AmerisourceBergen shapes health care delivery

AmerisourceBergen shapes health care delivery

CHESTERBROOK, Pa. — AmerisourceBergen Corp. has done much to redefine the role of the pharmaceutical wholesaler in recent years. The company has augmented its core drug distribution operation with a variety of capabilities that better position it to help business partners throughout the supply chain succeed. When one hears the name AmerisourceBergen today, it is

Nightengale takes reins at Good Neighbor Pharmacy

CONSHOHOCKEN, Pa. — Brian Nightengale has succeeded Dave Neu as president of AmerisourceBergen Corp.’s Good Neighbor Pharmacy. Neu, who has also been executive vice president of retail strategy at AmerisourceBergen, will retire this summer after more than three decades with the company. Nightengale had been president of Xcenda, AmeriscourceBergen’s health economics and outcomes consultancy. He

Good Neighbor Pharmacy president Neu to retire

Good Neighbor Pharmacy president Neu to retire

CONSHOHOCKEN, Pa. — David Neu, executive vice president of retail strategy at AmerisourceBergen Corp. and president of its Good Neighbor Pharmacy network, plans to retire this summer. AmerisourceBergen said Friday that Brian Nightengale, president of company subsidiary Xcenda, a health economics and outcomes consultancy, will take over as Good Neighbor Pharmacy president effective immediately. The

AmerisourceBergen closes PharMEDium acquisition

AmerisourceBergen closes PharMEDium acquisition

VALLEY FORGE, Pa. — AmerisourceBergen Corp. has finalized its acquisition of PharMEDium Healthcare Holdings Inc., a national provider of outsourced compounded sterile preparations (CSPs) to acute care hospitals. AmerisourceBergen announced the $2.575 billion cash deal, with private investment firm Clayton, Dubilier & Rice, early last month. Plans call for PharMEDium to become a part of AmerisourceBergen

AmerisourceBergen to buy PharMEDium for $2.6 billion

AmerisourceBergen to buy PharMEDium for $2.6 billion

VALLEY FORGE, Pa. — AmerisourceBergen Corp. plans to acquire PharMEDium Healthcare Holdings, Inc., a national provider of outsourced compounded sterile preparations (CSPs) to acute care hospitals, in a $2.575 billion cash deal. AmerisourceBergen said Tuesday that PharMEDium, which is being purchased from private investment firm Clayton, Dubilier & Rice, is the leading provider of customized outsourced

AmerisourceBergen to build three DCs

VALLEY FORGE, Pa. — This summer, AmerisourceBergen Corp. plans to begin construction on three new distribution centers. The new facilities will be located in Olive Branch, Miss.; Shakopee, Minn.; and Newburgh, N.Y. AmerisourceBergen said building is expected take 18 to 24 months to complete. AmerisourceBergen Drug Corp. (ABDC), the company’s drug distribution unit and largest

AmerisourceBergen aligns resources with Rx

AmerisourceBergen aligns resources with Rx

AmerisourceBergen earlier this month unveiled plans to add three new facilities — in Olive Branch, Miss.; Shakopee, Minn.; and Newburgh, N.Y. — to its distribution network, which handles some 35% of the pharmaceutical products sold in the United States. The multimillion-dollar investment to build and equip the warehouses will bring the amount of money the

AmerisourceBergen gives Mauch key role

VALLEY FORGE, Pa. — AmerisourceBergen Corp. has promoted Robert Mauch to executive vice president and president of AmerisourceBergen Drug Corp., the division that distributes pharmaceuticals and offers pharmacy management services. Mauch, 48, had been working as the company’s chief operating officer. He began his new duties on February 4, succeeding David Neu, who accepted the